<![CDATA[CYNAERA]]>https://www.cynaera.com/blogRSS for NodeWed, 08 Apr 2026 23:24:04 GMT<![CDATA[Personalized CRISPR Remission™ for Sarcoidosis: A Model for State-Dependent Precision Medicine]]>https://www.cynaera.com/post/crispr-remission-sarcoidosis69d6882a89f9e676eca1592cWed, 08 Apr 2026 20:31:45 GMT<![CDATA[25+ Long COVID Phenotyping List]]>https://www.cynaera.com/post/long-covid-phenotypes69d6611e5f4a19f844e50de0Wed, 08 Apr 2026 15:09:56 GMT<![CDATA[Personalized CRISPR Remission™ in Melanoma: A State-Dependent Innovation Transforming Durable Response]]>https://www.cynaera.com/post/crispr-remission-melanoma69d507dcb75c5d3058252ff4Tue, 07 Apr 2026 16:35:16 GMT<![CDATA[The Diagnostic Multiplier™: A Framework for Adjusting Disease Prevalence Based on Real World Diagnostic Capture]]>https://www.cynaera.com/post/diagnostic-multiplier69d4f07974eeae096e50c5c6Tue, 07 Apr 2026 12:58:33 GMT<![CDATA[CRISPR Remission for Lyme : A Flare-Aware Personalized Gene Editing Innovation]]>https://www.cynaera.com/post/crispr-remission-lyme69d3b64484368b4841055af4Mon, 06 Apr 2026 17:37:48 GMT<![CDATA[CRISPR Remission for Complex Regional Pain Syndrome (CRPS) : A Flare-Aware Gene Editing Framework]]>https://www.cynaera.com/post/crispr-remission-crps69d26d81f7044e6cf7af920eSun, 05 Apr 2026 16:22:08 GMT<![CDATA[State-Dependent Oral CRISPR Delivery: A Systems Framework for Uptake, EBV Targeting, and Gene Editing Efficiency]]>https://www.cynaera.com/post/oral-crispr69d18ef8f7044e6cf7ae46b7Sun, 05 Apr 2026 04:21:12 GMT<![CDATA[Remission Pathways in Long COVID: Drug Combinations, Chronicity & Socio-Biologic Terrain]]>https://www.cynaera.com/post/remission-lc69d169fdf7044e6cf7ae0905Sat, 04 Apr 2026 19:57:25 GMT<![CDATA[CRISPR Cell Therapy for Type 1 Diabetes: Beyond Immune Evasion Using Flare -Aware & Environmental Modeling for Durable Remission]]>https://www.cynaera.com/post/crispr-type-1-diabetes69cd334955ae1fb580a47757Thu, 02 Apr 2026 21:54:05 GMT<![CDATA[Pediatric Long COVID: A Public Health Crisis Demanding Recognition]]>https://www.cynaera.com/post/pediatric-lc69ce8d6bd6854e26a0aa7960Thu, 02 Apr 2026 18:52:05 GMT<![CDATA[Enhancing CRISPR Safety in Sickle Cell Disease Using State-Dependent Intervention]]>https://www.cynaera.com/post/crispr-sickle-cell69c2ab78b1bfd68174decd5eTue, 24 Mar 2026 17:47:55 GMT<![CDATA[CDF-Peds-LC™: A Composite Diagnostic Fingerprint for Pediatric Long COVID ]]>https://www.cynaera.com/post/cdf-peds-lc69b7233702111efc4a73e221Sun, 15 Mar 2026 23:34:35 GMT<![CDATA[Global Long COVID Prevalence: The CCUC™ Tiered Framework]]>https://www.cynaera.com/post/global-longcovid69b6e20a5a996f5d6694f9bfSun, 15 Mar 2026 17:56:42 GMT<![CDATA[Microdosing Air™ : Rebuilding Environmental Tolerance in Long COVID, ME/CFS, Dysautonomia, and Mast Cell Disorders]]>https://www.cynaera.com/post/microdosing-air69b0810ba547e1dd3d7dd0a9Tue, 10 Mar 2026 23:26:17 GMT<![CDATA[Mold Exposure as a Flare Amplifier in ME/CFS]]>https://www.cynaera.com/post/mecfs-mold69af05146b9018dbd070b615Mon, 09 Mar 2026 20:22:13 GMT<![CDATA[One New Long COVID Case Every Minute in the United States]]>https://www.cynaera.com/post/one-a-minute69ae14fa053d59350a125d5eMon, 09 Mar 2026 12:14:01 GMT<![CDATA[The Hidden Public Health Cost of AI Data Centers]]>https://www.cynaera.com/post/ai-data-centers69acdd16d66894c6d6f78ba5Sun, 08 Mar 2026 15:33:45 GMT<![CDATA[The Moral Adinig Method™: A Framework for Harm-Aware AI Learning]]>https://www.cynaera.com/post/moral-adinig-method69a324199d34acb7c436f651Sat, 28 Feb 2026 19:01:43 GMT<![CDATA[Aligned Intelligence Method (AIM™)]]>https://www.cynaera.com/post/the-aim699373ab6afbe985b7a3ee07Mon, 16 Feb 2026 20:45:38 GMT<![CDATA[Autoimmune Disease: Patterns, Timing, and the Cost of Snapshot Diagnosis]]>https://www.cynaera.com/post/autoimmune-data6961134b7b8171b5141a06dcFri, 09 Jan 2026 16:10:55 GMT